http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Xiongbing Chen,Ning Zhang 보안공학연구지원센터 2015 International Journal of Multimedia and Ubiquitous Vol.10 No.11
Finance is the core of modern economy, and the capital market as a part of the whole financial system, it is the key to the development of a country's economy. In this paper, we analyze the impact of stock index futures on the stock market by using CSI 300 index. The result shows that the stock index futures not significant effects on the volatility of spot market; however, there exist a co integration relationship in both long term and short term. Granger causality analysis shows that the stock index future is not Granger cause to CSI 300, while the CSI 300 is Granger cause stock index futures. On this basis, we put forward relevant policy suggestions.
Zhi Wang,Longxiang Wu,Shiyu Tong,Xiheng Hu,Xiongbing Zu,Yuan Li,Wei He,Longfei Liu,Minfeng Chen,Lin Qi 한국통합생물학회 2016 Animal cells and systems Vol.20 No.2
Resveratrol possesses a wide spectrum of pharmacological properties and has been an ideal alternative drug for the treatment of different cancers, including prostate cancer. However, the mechanisms by which resveratrol inhibits the growth of prostate cancer are still not fully elucidated. To understand the effect of resveratrol on the apoptosis and the epithelial-tomesenchymal transition (EMT) of prostate cancer as well as its related mechanism, we investigated the potential use of resveratrol in PC-3 prostate cancer cells in vitro using real-time PCR, fluorescence-activated cell sorting, Western blotting, etc. Resveratrol suppresses the PC-3 prostate cancer cell growth and induces apoptosis. Resveratrol also influences the expression of EMT-related proteins (increased E-cadherin and decreased Vimentin expression). Finally, resveratrol also suppressed Akt phosphorylation in PC-3 cells. This study indicates that resveratrol may be a potential anti-cancer treatment for prostate cancer; moreover, it provides new evidence that resveratrol suppresses prostate cancer growth and metastasis.